Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Entekno is a Turkish nanotechnology company specializing in the development and production of advanced functional materials, most notably its proprietary MicNo® technology. The company's flagship product is a unique form of zinc oxide that combines the safety of micron-sized particles with the transparency and high UV protection of nano-sized particles. Entekno serves the cosmetics, healthcare, and industrial coating sectors, providing high-performance UV filters and antimicrobial agents. Their innovations focus on sustainable and green chemistry to improve the safety and efficacy of personal care products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Entekno.